Treatment of triple negative breast cancer
OwnerLeonard Lothstein, Judith Soberman +1inventors
InventorsLeonard Lothstein, Judith Soberman, Tiffany N. Seagroves
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions comprising at least one of pivarubicin and benzarubicin, or a pharmaceutically acceptable salt thereof, and methods for using the compositions in the treatment of triple negative breast cancer (TNBC) by administering an effective amount of the compositions to a subject. In some instances, the subject is a mammal, including at least one of human, feline, and canine mammals.
Claims20
A method for treating triple negative breast cancer (TNBC), said method comprising administering to a subject an effective amount of at least one of pivarubicin and benzarubicin, or a pharmaceutically acceptable salt thereof.
A composition comprising at least one of pivarubicin and benzarubicin, or a pharmaceutically acceptable salt thereof, and further comprising a nonionic surfactant.
Dependencies are inferred from the claim text.